Safety Study of Abatacept in Sweden

Safety Study of Abatacept in Rheumatoid Arthritis Participants

NCT03696173 ·Status: COMPLETED

Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy

NCT00124982 ·Status: COMPLETED ·Phase: PHASE3

Abatacept Treatment in Polymyositis and Dermatomyositis

NCT01315938 ·Status: COMPLETED ·Phase: PHASE2

A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis

NCT00048932 ·Status: COMPLETED ·Phase: PHASE3

Does Abatacept Induce Regulatory B Cells in Patients With Rheumatoid Arthritis

NCT02885818 ·Status: COMPLETED

Phase IIIB Subcutaneous Abatacept Monotherapy Study

NCT00547521 ·Status: COMPLETED ·Phase: PHASE3

Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers

NCT00279734 ·Status: COMPLETED ·Phase: PHASE1

A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate

NCT04909801 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Introducing a Single IV Abatacept Treatment in RA Patients Currently Receiving Weekly SC Abatacept to Simulate a Holiday

NCT01846975 ·Status: COMPLETED ·Phase: PHASE4

Abatacept Versus Adalimumab Head-to-Head

NCT00929864 ·Status: COMPLETED ·Phase: PHASE3

An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF Therapy

NCT00162201 ·Status: COMPLETED ·Phase: PHASE1

Efficacy, Pharmacokinetics, Safety, and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japanese Patients

NCT01001832 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate

NCT00048568 ·Status: COMPLETED ·Phase: PHASE3

Real-world Clinical Efficacy of Abatacept in the T3 Data Registry

NCT01555879 ·Status: COMPLETED

Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA)

NCT00254293 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Remission and Joint Damage Progression in Early Rheumatoid Arthritis

NCT00122382 ·Status: COMPLETED ·Phase: PHASE3

A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs

NCT03086343 ·Status: COMPLETED ·Phase: PHASE3

A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate

NCT00420199 ·Status: COMPLETED ·Phase: PHASE3

Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients

NCT01351480 ·Status: COMPLETED ·Phase: PHASE3

A Phase III Study of Abatacept in Japanese Subjects With Rheumatoid Arthritis

NCT00484289 ·Status: COMPLETED ·Phase: PHASE3

Abatacept for the Treatment of Giant Cell Arteritis

NCT04474847 ·Status: RECRUITING ·Phase: PHASE3

Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting

NCT02037737 ·Status: COMPLETED

A Study to Evaluate Biomarkers to Predict Efficacy of Abatacept in Rheumatoid Arthritis

NCT03882008 ·Status: COMPLETED ·Phase: PHASE4

A Study in Healthy Adults and Adult Subjects With Rheumatoid Arthritis to Evaluate the Safety, Tolerability and Pharmacokinetics After Multiple Doses of ABT-494

NCT01741493 ·Status: COMPLETED ·Phase: PHASE1

A Study to Determine the Risk of Cancer in Rheumatoid Arthritis (RA) Patients Who Use Abatacept and Other Biologic Agents

NCT03670667 ·Status: COMPLETED